Halozyme Therapeutics, Inc. (HALO) Stock News, Earnings & History

(NASDAQ:HALO) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 9.92
52wk low: 3.86
EPS: -0.51
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 837.50M
Avg Vol (3m): 1.38M

Insider Trading Cheat Sheet

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Engler Robert Director Nov 29 Buy 5.57 15,000 83,550 165,000 Nov 29 07:15 PM
Shaffer James P VP & Chief Commercial Officer Nov 14 Buy 5.22 20,000 104,400 26,300 Nov 14 07:06 PM
FALBERG KATHRYN E Director Nov 13 Buy 5.21 50,000 260,500 160,000 Nov 14 07:12 PM
Kelley Kenneth J Director Aug 27 Buy 5.70 20,000 113,974 150,000 Aug 28 06:22 PM
Frost Gregory Ian CEO, President Aug 13 Buy 5.50 2,000 11,000 3,555,331 Aug 14 08:17 PM
KIRK RANDAL J Director Jun 05 Buy 7.48 5,463 40,863 331,395 Jun 05 05:41 PM
KIRK RANDAL J Director Jun 04 Buy 7.37 89,646 660,691 328,663 Jun 05 05:41 PM
KIRK RANDAL J Director Jun 01 Buy 7.39 99,080 732,201 283,840 Jun 05 05:41 PM
KIRK RANDAL J Director May 17 Buy 7.50 299,007 2,242,553 3,977,445 May 17 05:23 PM
KIRK RANDAL J Director May 16 Buy 7.44 344,910 2,566,130 3,678,438 May 17 05:23 PM
Yahoo, HV, Market Watch, The Wall St. Journal